Impressive Graft-versus-Host Disease-Free, Relapse-Free Survival in Matched Unrelated Donor Allogeneic Hematopoietic Stem Cell Transplantation Using Reduced-Intensity Conditioning and a Combination of Antithymocyte Globulin and Post-Transplantation Cyclophosphamide

Biol Blood Marrow Transplant. 2019 Nov;25(11):e352-e353. doi: 10.1016/j.bbmt.2019.07.005. Epub 2019 Jul 4.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antilymphocyte Serum
  • Cyclophosphamide
  • Graft vs Host Disease*
  • Hematopoietic Stem Cell Transplantation*
  • Humans
  • Transplantation Conditioning
  • Unrelated Donors

Substances

  • Antilymphocyte Serum
  • Cyclophosphamide